Capital Performance Advisors LLP Acrivon Therapeutics, Inc. Transaction History
Capital Performance Advisors LLP
- $325 Million
- Q3 2024
A detailed history of Capital Performance Advisors LLP transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Capital Performance Advisors LLP holds 32 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32Holding current value
$0% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ACRV
# of Institutions
53Shares Held
23.2MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA8.34MShares$00.0% of portfolio
-
Perceptive Advisors LLC New York, NY5.36MShares$00.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.14MShares$00.0% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA2.12MShares$00.0% of portfolio
-
Wellington Management Group LLP Boston, MA888KShares$00.0% of portfolio